Chronic venous insufficiency and venous leg ulceration

Journal of the American Academy of Dermatology

Volumn 44, Issue 3, 2001, Pages 401-424

  Valencia, Isabel C ^a   Falabella, Anna ^a   Kirsner, Robert S ^a   Eaglstein, William H ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCUZYME; ACETYLSALICYLIC ACID; ALGINIC ACID; ANTIBIOTIC AGENT; CADEXOMER IODINE; CALCIUM ALGINATE; COLLAGENASE; COMFEEL; DAFLON; DUODERM; ELASE; ENZYME; FIBRINOLYTIC AGENT; GRANULEX; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IFETROBAN; MACROGOL; OPSITE; PANAFIL; PAPAIN; PENTOXIFYLLINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; POLYURETHAN; RECOMBINANT EPIDERMAL GROWTH FACTOR; STANOZOLOL; SULODEXIDE; SURAMIN; TISSUE PLASMINOGEN ACTIVATOR; TRYPSIN;

ACNE; ANAMNESIS; ANTIBIOTIC THERAPY; ARTIFICIAL SKIN; BANDAGE; CHRONIC VEIN INSUFFICIENCY; CLINICAL FEATURE; CLINICAL TRIAL; DEBRIDEMENT; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; EDEMA; FIBRINOLYTIC THERAPY; FILM; FOAM; HIRSUTISM; HUMAN; HYDROCOLLOID; HYDROGEL; HYPERTENSION; LEG COMPRESSION; LEG ULCER; LIVER TOXICITY; METABOLIC DISORDER; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SHOE; SPLIT THICKNESS SKIN GRAFT; VASCULAR SURGERY; WOUND DRESSING;

EID: 0035090222     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.111633     Document Type: Article

References (237)

1. An approach to leg and foot ulcers: A brief overview
2. Epidemiology of chronic venous ulcers
3. Leg ulcers revisited
4. Chronic ulceration of the leg: Extent of the problem and provision of care
5. Hazards of compression treatment of the leg: An estimate from Scottish surgeons
6. Venous and non-venous leg ulcers: Clinical history and appearance in a population study
7. Leg ulcers
8. The Alexander House Group: Consensus paper on venous leg ulcer
9. Venous ulceration: Assessment, classification and management
10. Painful venous ulcers: Themes and stories about their impact on quality of life
11. A study of the impact of leg ulcers on quality of life: Financial, social, and psychological implications
12. Causes of venous ulceration: A new hypothesis?
13. The trap hypothesis of venous ulceration
14. Venous leg ulcers
15. New skin for old: Developments in biological skin substitutes
16. Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix
17. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers
18. Chronic leg ulcers: The impact of venous disease
19. Venous thromboembolism and other venous disease in the Tecumseh Community Health Study
20. Chronic ulcer of the leg: Clinical history
21. Socioeconomic impact of chronic venous insufficiency and leg ulcers
22. Cost analysis of dressing materials used in venous leg ulcers
23. Symposium on venous ulcers: Opening comments
24. Approaches to venous leg ulcer within the community; compression, pinch skin grafts and simple venous surgery
25. Definitions and guidelines for assessment of wounds and evaluation of healing
26. Medical costs of treating venous stasis ulcers: Evidence from a retrospective cohort study
27. Venous ulceration
28. Etiology of venous ulceration
29. Chronic venous insufficiency and venous ulceration
30. The relative importance of incompetent communicating veins in the production of varicose veins and venous ulcers
31. Venous pressure in patients with valvular incompetence of the veins of the lower limb
32. Valve reconstruction procedures for non-obstructive venous insufficiency: Rationale, techniques and results in 107 procedures with 2- to 8- year follow-up
33. Venous ulceration
34. Surgical options and indications for surgery in the treatment of patients with venous leg ulcers
35. The cause of venous ulceration
36. Effect of venous hypertension on canine hind limb lymph
37. Pericapillary fibrin cuffs in venous ulceration
38. Pericapillary fibrin in the ulcer-bearing skin of the lower leg: The cause of lipodermatosclerosis and venous ulceration
39. Transcutaneous oxygen tension in chronic venous insufficiency syndrome
40. Transcutaneous oxygen tension in patients with and without pericapillary fibrin cuffs in chronic venous insufficiency, porphyria cutanea tarda and non-venous leg ulcers
41. Possibilities and limitations of transcutaneous oxygen tension: Measurements in chronic venous insufficiency
42. Tissue oxygenation, venous ulcers and fibrin cuffs
43. Skin capillaries surrounding chronic venous ulcers demonstrate smooth muscle hyperplasia and increased laminin type IV collagen
44. Dermal pericapillary fibrin in venous disease and venous ulceration
45. Impairment of oxygen diffusion in edema
46. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers
47. Transcutaneous oxygen tension and capillary morphologic characteristics and density in patients with chronic venous incompetence
48. Oxygen tension on the skin of the gaiter area of limbs with venous disease
49. Transcutaneous oxygen tension in patients with post-thrombotic leg ulcers: Treatment with intermittent pneumatic compression
50. Hyperaemic hypoxia in venous ulceration
51. Differences between intracutaneous and transcutaneous skin oxygen tension in chronic venous insufficiency
52. Clinical parameters and transcutaneous oxygen measurements for the prognosis of venous ulcers
53. Oxygen and tissue repair
54. Microangiopathy in mild chronic venous incompetence (CVI): Morphological alterations and increased transcapillary diffusion detected by fluorescence videomicroscopy
55. Transcapillary and interstitial diffusion of Na-fluorescein in chronic venous insufficiency with white atrophy
56. The effect of sustained venous hypertension on the skin capillaries of the canine hind limb
57. Treatment of liposclerosis of the leg by fibrinolytic enhancement: A preliminary report
58. The fibrinolytic activity of varicose veins
59. Tumors: Wounds that do not heal
60. Healing of venous ulcers in an ambulatory care program: The role of chronic venous insufficiency and patient compliance
61. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration
62. Fibrin and fibrinogen-related antigens in patients with lipodermatosclerosis and venous ulceration
63. Factor XIII of blood coagulation modulates collagen biosynthesis by fibroblasts in vitro
64. Pericapillary fibrin cuffs in venous disease
65. Chronic wounds: Pathophysiologic and experimental considerations
66. Changes in the apparently normal limb in unilateral venous ulceration
67. Immunocytochemical analysis of growth factor and growth factor response cells in chronic venous stasis ulcers
68. Extravasation of macromolecules and possible trapping of transforming growth factor-β in venous ulceration
69. Increasing erythrocyte aggregability with the progressive grades of chronic venous insufficiency: Importance and mechanisms
70. Importance of red cell aggregation in venous pathology
71. White cell accumulation in dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin
72. Pathophysiology of venous leg ulceration-an update
73. Haemo-concentration and accumulation of white cells in the feet during venous stasis
74. Histological study of white blood cells and their association with lipodermatosclerosis and venous ulceration
75. Management of leg ulcers
76. Risk factors for chronic venous insufficiency: A dual case-control study
77. Leg ulcer etiology - A cross sectional population study
78. Long-term evolution of varicose veins-11 year follow-up
79. The role of primary varicose veins in venous ulceration
80. Diagnosis and treatment of venous ulceration
81. Impaired postural vasoconstriction: A contributory cause of edema in patients with chronic venous insufficiency
82. Venous ulceration: Pathology
83. Is the postphlebitic leg always postphlebitic? Relation between phlebographic appearances of deep vein thrombosis and late sequelae
84. Venous ulcers: New treatment for an old disease
85. The clinical spectrum of lipodermatosclerosis
86. Successful methods of treating leg ulcers: The tried and true, plus the novel and new
87. Thalassemia minor and painful ulcers of lower extremities
88. Vasculitis and atrophie blanche
89. Increased plasma activity of plasminogen activator inhibitor I (PAl-I) in two patients with Klinefelter's syndrome complicated by leg ulcers
90. Atrophie blanche in chronic myelogenous leukemia
91. Sneddon's syndrome (livedo reticularis and cerebral thrombosis) with livedo vasculitis and anticardiolipin antibodies
92. Livedo reticularis, porcelain-white scars, and cerebral thromboses
93. Atrophie blanche in a patient with gamma-heavy chain disease
94. Atrophie blanche
95. Extravascular fibrin deposition in response to venous hypertension: The cause of venous ulcers
96. Ulceres de jambes et troubles trophiques d'origine veineuse (donnes tirees de I'etude d'un millier d'ulcereux hospitalises)
97. Sclerosing panniculitis: A clinicopathologic assessment
98. Acute lipodermatosclerosis is associated with venous insufficiency
99. Fibrinolytic abnormalities in 2 different cutaneous manifestations of venous disease
100. Uncommon causes of ulcers
101. Noninvasive diagnostic assessment of peripheral vascular disease
102. Diabetic foot ulcerations: An overview
103. Management of wounds in the diabetic foot
104. Infections in the diabetic foot
105. Pyoderma gangrenosum
106. Spontaneous necrosis of the skin associated with cryofibrinogenemia, cryoglobulinemia, and homocystinuria
107. Autoimmune ulceration of the leg
108. Basal cell carcinoma arising in venous ulcer and mimicking granulation tissue
109. Single-visit venous ulcer assessment clinic: The first year
110. Venous ulcers
111. Draft guideline: Diagnosis and treatment of venous leg ulcers
112. Venous hemodynamic abnormalities in patients with leg ulceration
113. Duplex examination
114. Patients evaluated for venous disease may have other pathological conditions contributing to symptomatology
115. Effect of leg elevation on the skin microcirculation in chronic venous insufficiency
116. Chronic venous insufficiency of the lower extremity
117. Sustained compression and healing chronic venous ulcers
118. Fifteen-year results of ambulatory compression therapy for chronic venous ulcers
119. Compression therapy of the legs: A review
120. Effects of intermittent compression treatment on skin perfussion and oxygenation in lower legs with venous ulcers
121. Dermal lymphangiopathy in chronic venous incompetence
122. Die lymphkinetik beim postthrombotischen syndrom unter kompressionsverbanden
123. Tourniquet induction of fibrinolysis
124. Effect of venous occlusion on coagulation and fibrinolytic components in normal subjects
125. Effect of external pneumatic intermittent compression on fibrinolysis in man
126. Venous reflux: Quantification and correlation with the clinical severity of chronic venous disease
127. Reduktion der venosen ambulatorischen hypertonie durch veneneinengung
128. La contention élastique chez I'artériopathie
129. Arterial disease in chronic leg ulceration: An underestimated hazard? Lothian and Forth Valley leg ulcer study
130. Overview of chronic wounds and recent advances
131. A systematic review of compression treatment for venous leg ulcers
132. Compression treatment of the lower extremities, particularly with compression stockings
133. Ambulatory elasto-compressive treatment of the lower extremities particularly with elastic stockings
134. Heel ulcers in patients with long-standing diabetes who wear antiembolism stockings
135. Value of graduated compression stockings in deep venous insufficiency
136. Management of chronic venous leg ulcers: A literature-guided approach
137. Compression therapy: Theory and practice
138. Stasis ulcers: The role of compliance in healing
139. Regulating the pressure under compression bandages for venous ulcers
140. Compression bandaging in the treatment of venous leg ulcers: A guide to the evidence for the effective selection of bandages
141. Care of venous leg ulcers
142. Wound healing and chronic wounds
143. A therapeutic approach to venous ulcers
144. Wound healing: Practical aspects
145. Study of sequential compression therapy in the treatment of nonhealing chronic venous ulcers
146. Sequential pneumatic compression for lymphedema
147. The sequential pneumatic compression device in surgery for lymphedema of the limbs
148. Compression therapy
149. Pinch skin grafting or porcine dermis in venous ulcers: A randomised clinical trial
150. Nursing management of venous ulceration
151. Risk factors associated with the failure of a venous ulcer to heal
152. Using wound debridement to help achieve the goals of care
153. Instrument/sharp debridement of non-viable tissue in wound
154. Enzymatic debriding preparations
155. Chronic wounds
156. Debridement and management of exudative wounds
157. Debridement
158. Surgical versus enzymatic debridement
159. Moist environment for healing: Matching the dressing to the wound
160. Hydrocolloid occlusive dressing management of leg ulcers
161. Occlusive wound dressings to prevent bacterial invasion and wound infection
162. The effect of two new dressings on epidermal wound healing
163. Occlusive dressings and wound healing
164. Do dressings influence the healing of chronic venous ulcers?
165. Comparative study of three primary dressings in the healing of chronic venous ulcers
166. A prospective, randomized trial of Unna's boots versus hydroactive dressings in the treatment of venous stasis ulcers
167. Proteolytic enzyme activity in the granulation tissue of the human burn wound
168. Evaluation of two enzyme preparations: Trypure and veridase in traumatic ulcers
169. Debridement of experimental full-thickness skin burns of rats with enzyme fractions derived from pineapple stem
170. Preliminary evaluation of vibriolysis, a novel proteolytic enzyme composition suitable for the debridement of burn wound eschar
171. Occlusive wound dressings: Why, when, which?
172. Proteolytic enzymes in wound healing: The role of enzymatic debridement
173. The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremities
174. Topically applied tPA for the treatment of venous ulcers
175. Prospective randomized study comparing the debriding effect of krill enzymes and a non-enzymatic treatment in venous leg ulcers
176. Future prospects of proteolytic enzymes and wound healing
177. Occlusive dressings
178. Growth factors: Their biology and promise in dermatologic diseases and tissue repair
179. Peptide growth factors and wound healing
180. Stimulation of healing of chronic wounds by epidermal growth factor
181. Growth factors in wound healing
182. Suramin application decreases epithelialization of porcine partial thickness wounds: Blockage of wound growth factor as a possible mechanism of action
183. Mupirocin treatment of exudative venous ulcers
184. Topical antibiotic therapy
185. Wound healing: The effects of topical antimicrobial agents
186. Comparison of the effects of commonly used wound agents on epithelialization and neovascularization
187. The relative toxicity index for wound cleansers
188. Should iodine be reconsidered in wound management? A report of a consensus meeting on the use of iodine in wound care
189. Iodosorb compared to standard treatment in chronic venous leg ulcers - A multicenter study
190. Multicenter trial of cadexomer iodine to treat venous stasis ulcers
191. Oxpentifylline treatment of venous ulcers of the legs
192. Bacterial studies of leg ulcers
193. The effect of a semiocclusive dressing on the microbial population in superficial wounds
194. Prevalence of wound infection under occlusive dressings: A collective survey of reported research
195. Systemic administration of antibiotics in the management of venous ulcers: A randomized clinical trial
196. C-reactive protein levels in venous ulceration: An indication of infection?
197. Stanozolol in treatment of leg ulcers due to cryofibrinogenemia
198. Venous lipodermatosclerosis: Treatment by fibrinolytic enhancement and elastic compression
199. Stanozolol as a novel therapeutic agent in dermatology
200. Fibrinolysis and fat necrosis
201. Blood and vein-wall fibrinolytic activity in health and vascular disease
202. Fibrinolytic enhancement by stanozolol: A double blind trial
203. Atherogenic side effects of anabolic steroids on serum lipid levels
204. Efficacy of fibrinolytic enhancement with stanozolol in the treatment of venous insufficiency
205. Transcutaneous oxygen tensions in assessing the treatment of healed venous ulcers
206. Liver pathology associated with the use of anabolic-androgenic steroids
207. Clinical benchmark for healing of chronic venous ulcers
208. A bilayered skin construct (Apligraf) accelerates complete closure of hard-to-heal venous ulcers
209. The effect of pentoxifylline on polymorphonuclear cell adhesion to cultured endothelial cells
210. The influence of pentoxifylline on interactions between blood vessel wall and platelets
211. Oxpentifylline in endotoxaemia
212. Randomised, double blind placebo controlled trial of pentoxyphilline in the treatment of venous leg ulcers
213. Pentoxifylline (Trental) accelerates the healing of venous ulcers in a double of blind randomised study
214. Randomised trial of oral aspirin for chronic venous leg ulcers
215. Efficacy of Daflon 500 mg in venous leg ulcer healing: A double-blind, randomized, controlled versus placebo trial in 107 patients
216. Treatment of venous leg ulcers with Sulodexide
217. Guidelines for the management of chronic venous leg ulceration: Report of a multidisciplinary workshop
218. Techniques of split-thickness skin grafting for lower extremity ulcerations
219. Techniques for split-thickness skin grafting
220. Split-thickness skin grafting of leg ulcers
221. Studies on the effectiveness of surgical management of chronic leg ulcers
222. Surgical management of ulcerative stasis disease of the lower extremities
223. Surgical treatment of large stasis ulcer: A review of 129 cases
224. Split-skin grafting of varicose leg ulcers: A survey and the importance of assessment of risk factor in predicting outcome from the procedure
225. Why skin grafts fail
226. The mesh skin graft
227. Relation between postphlebitic changes in the deep veins and results of surgical treatment of venous ulcers
228. Free flap valvular transplantation for refractory venous ulceration
229. Free tissue transfer in treatment of the recalcitrant chronic venous ulcer
230. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent
231. Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony stimulating factor in chronic leg ulcers
232. Granulocytemacrophage colony-stimulating factor - A novel therapy in the healing of chronic ulcerative lesions
233. Treatment of non-healing ulcers with rh-GM-CSF and skin grafts
234. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers
235. Use of a non-contact radiant heat bandage for the treatment of chronic venous stasis ulcers
236. Augmentation of wound healing using monochromatic infrared energy